Stewart P M, Corrie J, Seckl J R, Edwards C R, Padfield P L
Department of Medicine, Western General Hospital, Edinburgh.
Lancet. 1988 May 28;1(8596):1208-10. doi: 10.1016/s0140-6736(88)92020-x.
In 70 paired insulin tolerance tests (ITTs) and short 'Synacthen' tests (SSTs), both of which have been advocated for assessment of the hypothalamo-pituitary-adrenal (HPA) axis, there were 51 passes on both tests, 9 failures on both, and 10 discrepant results (9 failures on the SST, 1 failure on the ITT). There was a close correlation between the maximum cortisol value achieved in the two tests. A survey of British endocrinologists showed that only 24% used the SST to assess the HPA axis. It is suggested that the SST should be used for the initial assessment of the HPA axis and the ITT reserved for patients who fail the SST, those on corticosteroid therapy, and those who have had an acute pituitary insult within 14 days.
在70组配对的胰岛素耐量试验(ITT)和短效促肾上腺皮质激素(SST)试验中,这两种试验都被提倡用于评估下丘脑 - 垂体 - 肾上腺(HPA)轴,两种试验均通过的有51组,两种试验均失败的有9组,结果不一致的有10组(SST试验失败9组,ITT试验失败1组)。两种试验中达到的最大皮质醇值之间存在密切相关性。一项对英国内分泌学家的调查显示,只有24%的人使用SST来评估HPA轴。建议SST应用于HPA轴的初始评估,而ITT则保留给SST试验失败的患者、接受皮质类固醇治疗的患者以及在14天内有急性垂体损伤的患者。